SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2)

SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2) This biosafety advisory is being provided by the Public Health Agency of Canada (PHAC) to assist clinical, diagnostic, and research laboratories in implementing proper biosafety procedures to handle samples that may contain SARS-CoV-2. 2020-05-08 Public Health Agency of Canada open-ouvert@tbs-sct.gc.ca Health and SafetySARS-CoV-2Biosafety advisoryclinicaldiagnosticand research laboratories. SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2)HTML https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/biosafety-directives-advisories-notifications/novel-coronavirus-january-27.html SARS-CoV-2 (Severe acute respiratory syndrome-related coronavirus 2)HTML https://www.canada.ca/fr/sante-publique/services/biosecurite-biosurete-laboratoire/directives-avis-avis-speciaux-matiere-biosecurite/nouveau-coronavirus-27-janvier.html

This biosafety advisory is being provided by the Public Health Agency of Canada (PHAC) to assist clinical, diagnostic, and research laboratories in implementing proper biosafety procedures to handle samples that may contain SARS-CoV-2.

Data and Resources

Similar records